Skip to content

A Comparative Study on Therapeutic Effect of Metformin and Sitaformin in Infertile Women with polycystic ovary syndrome (PCOS) undergoing intra-cytoplasmic sperm injection (ICSI)

A Comparative Study on Therapeutic Effect of Sitagliptin-Metformin and Metformin in Infertile Women with polycystic ovary syndrome (PCOS) undergoing intra-cytoplasmic sperm injection (ICSI)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191127045519N1
Enrollment
80
Registered
2019-12-10
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Control group: oral rehydration salts (ORS, Poursina, Tehran, Iran) two times daily. Intervention 2: Intervention group 1: received Met (Glucophage, Merck, West Drayton, UK
500 mg two times daily). Intervention 3: Intervention group2: received Sita (Januvia, Merck,West Drayton, UK. 50 mg two times daily). Intervention 4: Intervention group3: which received Sitaformin (Ja

Sponsors

Arak university
Lead Sponsor
Infertility and Reproductive Health Research Center Shahid Beheshti University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: infertile Patients with polycystic Ovary Syndrome age range of 25 to 35 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
No. of Oocyte retrieved. Timepoint: once, in day of puncture. Method of measurement: Oocyte retrieval was performed by ultrasound-guided transvaginal aspiration using a single-lumen needle.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDelbar Daneshjou

Arak niversity

d.daneshjou@yahoo.com+98 21 2249 2891

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026